Cargando…
Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)
BACKGROUND: KIR/HLA mismatch in hematopoietic stem cell transplantation (HSCT), particularly in patients with acute myeloid leukemia (AML), was related to decreased recurrence rates, improved engraftment, and a reduction in graft-versus-host disease, according to recent research (GVHD). Uncertainty...
Autores principales: | Bakhtiari, Tahereh, Ahmadvand, Mohammad, Yaghmaie, Marjan, Sadeghi, Alireza, Mousavi, Seied Asadollah, Rostami, Tahereh, Ganjalikhani-Hakemi, Mazdak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283280/ https://www.ncbi.nlm.nih.gov/pubmed/37340345 http://dx.doi.org/10.1186/s12865-023-00548-1 |
Ejemplares similares
-
HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients
por: Zhao, X-Y, et al.
Publicado: (2014) -
Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis
por: Jalili, Mahdi, et al.
Publicado: (2018) -
Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease-Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease-19
por: Barkhordar, Maryam, et al.
Publicado: (2022) -
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
por: Chang, Ying-Jun, et al.
Publicado: (2016) -
The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major
por: Rostami, Tahereh, et al.
Publicado: (2021)